BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2787334)

  • 1. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.
    Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J
    J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Accurate Confirmation of Human Immunodeficiency Virus Type 1 (HIV-1) and 2 (HIV-2) Infections with a Dot blot assay Using Recombinant p24, gp41, gp120 and gp36 Antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Roostaee MH; Forooshani RS; Kazemnejad A
    Int J Med Sci; 2004; 1(3):193-200. PubMed ID: 15912198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a confirmatory enzyme-linked immunosorbent assay for HIV-1 antibodies.
    Chiang CS; Grove T; Cooper M; Cuan J; Kowalski A; Parcells K; Tsunokawa M; Rosenberg M; Arcuri E; Franklin S
    Clin Chem; 1989 Jun; 35(6):946-52. PubMed ID: 2659223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliable detection of individuals seropositive for the human immunodeficiency virus (HIV) by competitive immunoassays using Escherichia coli-expressed HIV structural proteins.
    Dawson GJ; Heller JS; Wood CA; Gutierrez RA; Webber JS; Hunt JC; Hojvat SA; Senn D; Devare SG; Decker RH
    J Infect Dis; 1988 Jan; 157(1):149-55. PubMed ID: 3275722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population.
    Tribe DE; Reed DL; Lindell P; Kenealy WR; Ferguson BQ; Cybulski R; Winslow D; Waselefsky DM; Petteway SR
    J Clin Microbiol; 1988 Apr; 26(4):641-7. PubMed ID: 3259246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
    Busch MP; el Amad Z; McHugh TM; Chien D; Polito AJ
    Transfusion; 1991 Feb; 31(2):129-37. PubMed ID: 1899951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic env gp41 peptide as a sensitive and specific diagnostic reagent in different stages of human immunodeficiency virus type 1 infection.
    Närvänen A; Korkolainen M; Suni J; Korpela J; Kontio S; Partanen P; Vaheri A; Huhtala ML
    J Med Virol; 1988 Oct; 26(2):111-8. PubMed ID: 2460585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of human serum antibodies to human immunodeficiency virus (HIV) using recombinant ENV and GAG antigens.
    Kenealy W; Reed D; Cybulski R; Tribe D; Taylor P; Stevens C; Matthews T; Petteway S
    AIDS Res Hum Retroviruses; 1987; 3(1):95-105. PubMed ID: 3304356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of serum HIV-Ag related to the major core protein (p24) in persons at risk for AIDS.
    Borghi V; De Rienzo B; Pietrosemoli P; Pecorari M; Mongiardo N; Pellegrino F; Zanchetta GP; Lami G; Squadrini F
    Microbiologica; 1989 Jan; 12(1):81-3. PubMed ID: 2497304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive sera do not react with human immunodeficiency virus (HIV) gag-encoded recombinant antigen.
    Bukrinsky MI; Syrtsev VA; Popov SA; Barsov EV; Chaplinskas SA; Karamov EV
    J Med Virol; 1989 Jan; 27(1):72-5. PubMed ID: 2466101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2.
    Fransen K; Pollet DE; Peeters M; van Kerckhoven I; Beelaert G; Vercauteren G; Piot P; van der Groen G
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):939-46. PubMed ID: 1794364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.
    Hashida S; Hashinaka K; Ishikawa S; Ishikawa E
    J Clin Lab Anal; 1997; 11(5):267-86. PubMed ID: 9292394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of recombinant human immunodeficiency virus gag precursor and gag/env fusion proteins and a synthetic env peptide as diagnostic reagents.
    Shoeman RL; Young D; Pottathil R; Victor J; Conroy RR; Crowl RM; Coleman T; Heimer E; Lai CY; Ganguly K
    Anal Biochem; 1987 Mar; 161(2):370-9. PubMed ID: 3495201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterially expressed core and envelope proteins of human immunodeficiency virus type-1 (HIV-1): comparative evaluation in detection of type-specific antibodies.
    Kovác J; Zachar V; Brůcková M; Ujhélyi E; Füst G; Mayer V; Zajac V
    Acta Virol; 1992 Aug; 36(4):337-46. PubMed ID: 1282776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.
    Burke DS; Redfield RR; Putman P; Alexander SS
    J Clin Microbiol; 1987 Jan; 25(1):81-4. PubMed ID: 3540002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
    Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
    J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 neutralizing antibodies in urine from seropositive individuals.
    Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.